ConductScience.org, home

Paper57451

Controlled trial of 1apha-hydroxycholecalciferol in chronic renal failure.

Tougaard L and 5 others. Lancet, 1976. Cited by 104 papers, by iCite.

Cite this record

ConductScience Library. Controlled trial of 1apha-hydroxycholecalciferol in chronic renal failure. Papers, record 57451. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/57451

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Controlled trial of 1apha-hydroxycholecalciferol in chronic renal failure.
PubMed
Journal
Lancet
PubMed
Year
1976
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
104
iCite
Relative citation ratio, by iCite
4.29
iCite
Revised in PubMed
2019-06-10
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tougaard LL
2Sorensen EE
3Brochner-Mortensen JJ
4Christensen MSM S
5Rodbro PP
6Sorensen AWA W

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HydroxycholecalciferolsMajor topic
Kidney Failure, ChronicMajor topic
Adult
Aged
Alkaline Phosphatase
Bone and Bones
Brain Injuries
Calcium
Clinical Trials as Topic
Female
Humans
Hydroxyproline
Hypocalcemia
Intestinal Absorption
Kidney
Magnesium
Male
Middle Aged
Parathyroid Hormone
Phosphorus

Source PubMed

Download CSV of topics

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 104 citations.

PMIDTitleJournalYearIn PapersSource
26812502Effect of Vitamin D Receptor Activators on Glomerular Filtration Rate: A Meta-Analysis and Systematic Review.PLoS One2016https://conductscience.org/library/papers/26812502PubMed
24719814The effect of calcium with or without calcitriol supplementation on renal function in patients with hypovitaminosis d and chronic kidney disease.Nephrourol Mon2014https://conductscience.org/library/papers/24719814PubMed
22461248Treatment options of secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease stages 3 and 4: an historic review.Clin Cases Miner Bone Metab2009https://conductscience.org/library/papers/22461248PubMed
14580225Secondary hyperparathyroidism in children with chronic renal failure: pathogenesis and treatment.Paediatr Drugs2003https://conductscience.org/library/papers/14580225PubMed
7423698Serum calcium and phosphate concentrations and parathyroid morphology in rats treated with vitamin D metabolites.Urol Res1980https://conductscience.org/library/papers/7423698PubMed
6357106Effect of low dose 1 alpha-hydroxycholecalciferol on glomerular filtration rate in moderate renal failure.Arch Dis Child1983https://conductscience.org/library/papers/6357106PubMed
3153271Long-term suppression of hyperparathyroidism by phosphate binders in uremic children.Pediatr Nephrol1987https://conductscience.org/library/papers/3153271PubMed
912593Treatment of renal osteodystrophy with 1alpha-hydroxycholecalciferol (1alpha-OH-D3) in conjunction with a high dialysate calcium.Calcif Tissue Res1977https://conductscience.org/library/papers/912593PubMed
9125491alpha-Hydroxycholecalciferol in children with renal osteodystrophy.Calcif Tissue Res1977https://conductscience.org/library/papers/912549PubMed
9125111alpha-Hydroxycholecalciferol in renal osteodystrophy.Calcif Tissue Res1977https://conductscience.org/library/papers/912511PubMed
879833Renal osteodystrophy in nondialysed adolescents. Long-term treatment with 1alpha-hydroxycholecalciferol.Arch Dis Child1977https://conductscience.org/library/papers/879833PubMed
832080Effect of 1-alpha-hydroxycholecalciferol on magnesium metabolism in chronic renal failure.Br Med J1977https://conductscience.org/library/papers/832080PubMed
728099Synthesis of 1 alpha-hydroxy[7-3H]cholecalciferol and its metabolism in the chick.Biochem J1978https://conductscience.org/library/papers/728099PubMed
700945Seasonal variations in urinary excretion of calcium and magnesium in healthy subjects and patients with renal calculus and chronic renal failure.Int Urol Nephrol1978https://conductscience.org/library/papers/700945PubMed
334342Controlled therapeutic trial of 1alpha-hydroxycholecalciferol in chronic renal failure.Calcif Tissue Res1977https://conductscience.org/library/papers/334342PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
PTH5741PubTator's text mininghttps://conductscience.org/library/genes/5741

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/57451

GET https://conductscience.org/api/papers/v1/57451/authors